Rev Bras Oftalmol.2022;81:e0020

Malignant hypertensive retinopathy secondary to systemic lupus erythematous in adolescent

Thiago Sande , Ana Luiza Mansur , Fernanda Bekman Diniz Mitleg , Tais , Felipe Bekman Diniz Mitleg , Eduardo de França

DOI: 10.37039/1982.8551.20220020

ABSTRACT

Systemic lupus erythematosus may present ophthalmological involvement, usually benign, and the most common changes are dry eye syndrome and cataract. In patients with stable disease, ophthalmologic damage appears to be related to long-term systemic treatment, emphasizing the importance of routine complete ophthalmologic examination. However, in full-blown disease, especially when there is renal involvement, early treatment should start with systemic steroid therapy and supportive measures, to avoid major repercussions, such as hypertensive crises that may lead to death.

Malignant hypertensive retinopathy secondary to systemic lupus erythematous in adolescent

Comments (0)